Journals / Türk Osteoporoz Dergisi / 2012 / Cilt: 18 - Sayı: 2

Secondary osteoporosis as a result of marfan syndrome: A case report

Sekonder osteoporoz nedeni marfan sendromu: Olgu sunumu

Pages
68–71
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we aimed to point out that MFS is a cause of seconder osteoporosis and the reason for developing osteoporosis in general by examining the case where a 29 year old male MFS patient who visited our outpatient clinics with complaints of low back, and right leg pain exhibited decrease in BMD. (Turkish Journal of Osteoporosis 2012;18: 68-71)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Marfan syndrome (MFS) is an autosomal dominant disorder developing as a result of mutation of fibrillin-1 gene located on chromosome 15.
📊
Key Findings & Data:MFS also causes secondary osteoporosis, and leads to a decrease in bone mineral density (BMD), and an increase in fracture risk.
💡
Conclusion & Impact:In this report, we aimed to point out that MFS is a cause of seconder osteoporosis and the reason for developing osteoporosis in general by examining the case where a 29 year old male MFS patient who visited our outpatient clinics with complaints of low back, and right leg pain exhibited decrease in BMD. (Turkish Journal of Osteoporosis 2012;18: 68-71)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Marfan syndrome (MFS) is an autosomal dominant disorder developing as a result of mutation of fibrillin-1 gene located on chromosome 15. This collagen vascular disease causes multisystem abnormalities involving musculoskeletal, cardiovascular, ocular, and neurologic systems. MFS also causes secondary osteoporosis, and leads to a decrease in bone mineral density (BMD), and an increase in fracture risk. In this report, we aimed to point out that MFS is a cause of seconder osteoporosis and the reason for developing osteoporosis in general by examining the case where a 29 year old male MFS patient who visited our outpatient clinics with complaints of low back, and right leg pain exhibited decrease in BMD. (Turkish Journal of Osteoporosis 2012;18: 68-71)

Özet

Marfan sendromu (MFS) 15. krozomdaki fibrillin-1 gen mutasyonu sonucu gelişen otozomal dominat bir hastalık olup, kas-iskelet sistemi, kardiyovasküler, oküler ve nörolojik sistem problemlerine sebep olan multisistemik bir bağ dokusu hastalığıdır. MFS ayrıca sekonder osteoporoz nedeni olup, kemik mineral yoğunluğunda (KMY) azalma ve kırık riskinde artışa yol açar. Bu yazıda bel ve sağ bacakta ağrı yakınması ile polikliniğimize başvuran 29 yaşındaki erkek hastanın yapılan KMY ölçümünde azalma tespit edilmesi nedeniyle MFS’nin sekonder osteoporoz nedenlerinden biri olduğuna ve osteoporoz gelişiminin sebeplerine dikkati çekmek amaçlanmıştır. (Türk Os­te­opo­roz Dergisi 2012;18: 68-71)

🔖

Cite This Article

DOĞU, B., KURAN, K. B., YILMAZ, F., ÖNCÜ, J., ŞİRZAİ, H. (2022). Secondary osteoporosis as a result of marfan syndrome: A case report. Türk Osteoporoz Dergisi, Cilt: 18 - Sayı: 2, 68–71. https://ajindex.com/articles/639891

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Raanani E, Ghosh P. The multidisciplinary approach to the marfan patient. Isr Med Assoc J 2008;10:171-74
  2. Jones KB, Sponseller PD, Erkula G, Sakai L, Ramirez F, Dietz HC 3rd, et al. Symposium on the musculoskeletal aspects of Marfan syndrome: Meeting report and state of Science. J Orthop Res 2007;25:413-22
  3. Moura B, Tubach F, Sulpice M, Boileau C, Jondeau G, Muti C, et al. Bone mineral density in Marfan syndrome. A large case-control study. J Bone Spine 2006;73:733-35. Epub 2006 Sep 14
  4. Yuan SM, Jing H. Marfan’s syndrome: an overview. Sao Paulo Med 2010;128:360-6
  5. Giampietro PF, Peterson M, Schneider R, Davis JG, Raggio C, Myers E, et al. Assessment of bone mineral density in adults and children with Marfan syndrome. Osteoporosis Int 2003;14:559-63. Epub 2003 Jul 3
  6. Judge DP, Dietz HC. Marfan’s syndrome. Lancet 2005;366:1965-76
  7. Gray JR, Bridges AB, Mole PA, Pringle T, boxer M, Paterson CR. Osteoporosis and Marfan syndrome. Postgrad Med J 1993;69:373-75
  8. Frydman M. The marfan syndrome. Isr Med Assoc J 2008;10:175-8
  9. Lebreiro A, Martins E, Cruz C, Almeida J, Maciel MJ, Cardoso JC, Lima CA. Marfan syndrome: clinical manifestations, pathophysiology and new Outlook on drug therapy. Rev Port Cardiol 2010;29:1021-36
  10. Avivi E, Arzi H, Paz L, Caspi I, Checkik A. Skeletal manifestations of marfan syndrome. Isr Med Assoc J 2008;10:186-8
  11. Dean JC. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 2007;15:724-33. Epub 2007 May 9
  12. Ha HI, Seo JM, Lee SH, Kang JW, Goo HW, Lim TH, et al. Imaging of marfan syndrome: multisystemic manifestations. Radiographics 2007;27:989-1004
  13. Carter N, Duncan E, Wordsworth P. Bone mineral density in adults with Marfan syndrome. Rheumatology (Oxford) 2000;39:307-9
  14. Uçan Ö, Taşcı S, Ovayolu N. Osteoporozda risk faktörleri ve korunmanın önemi. Fırat Sağlık Hizmetleri Dergisi 2007;2:73-86
  15. Woo C, Chang LL, Ewing SK, Bauer DC. Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J Am Geriatr Soc 2008;56:1171-6
  16. Pearson DA. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract 2007;22:517-44
  17. Le Parc JM, Plantin P, Jandeau G, Goldschild M, Albert M, Boilequ C. Bone mineral density in sixty adult patients with Marfan syndrome. Osteoporosis Int 1999;10:475-9
  18. Le Parc JM, Molcard S, Tubach F. Bone mineral density in Marfan syndrome. Rheumatology (Oxford) 2001;40:358-9
  19. Giampietro